SST2-positive Neuroendocrine Neoplasms

Clinical trial pipeline · Data from ClinicalTrials.gov

See which SST2-positive Neuroendocrine Neoplasms trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT07129252

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tu…

This Phase 1/2, multicenter, open-label, FIH study aims to evaluate the safety, tolerability, PK, and preliminary antitumor activity of CRN09682 in participants…

United States150 participantsStarted 2025-11-26

Treatment: CRN09682

All recent trials (2 shown)

Active — Not RecruitingPhase 2

NCT03454763

Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors

Randomized Phase II Trial in sstr2 Positive Tumors to Optimize the Interval Between Cycles of PRRT With 177lu-dotatate

Italy618 participantsStarted 2016-05-26

Treatment: PRRT every 5 weeks, PRRT every 8-10 weeks